ADARx Pharmaceuticals, Inc.
$12.84
Mkt Cap 1.43B
Developer of siRNA drugs, which switch off specific disease-causing genes, aimed at treating a broad range of diseases.
adarx.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
Run a full DCF model with Monte Carlo simulation.
Key Metrics
Loading full analysis…
Running full 6-factor analysis…